User profiles for Bo Yeun Yang
Bo Yeun YangEckert & Ziegler Radiopharma, Inc. Verified email at ezag.com Cited by 577 |
Development of a multimodal imaging probe by encapsulating iron oxide nanoparticles with functionalized amphiphiles for lymph node imaging
Aim: We tried to develop a multimodal iron oxide nanoparticles (IO NP) imaging probe by an
encapsulation method using specific amphiphiles for 68 Ga-labeling and lymph node-…
encapsulation method using specific amphiphiles for 68 Ga-labeling and lymph node-…
[HTML][HTML] Development of a complementary PET/MR dual-modal imaging probe for targeting prostate-specific membrane antigen (PSMA)
We tried to develop a dual-modal PET/MR imaging probe using a straightforward one-pot
method by encapsulation with specific amphiphiles. In this study, iron oxide (IO) nanoparticles …
method by encapsulation with specific amphiphiles. In this study, iron oxide (IO) nanoparticles …
Formulation of 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study
… Author links open overlay panel Bo Yeun Yang a b c , Jae Min Jeong a b c , Young Joo
Kim a b , Jae Yeon Choi a b c , Yun-Sang Lee a , Dong Soo Lee a c , June-Key Chung a b c , …
Kim a b , Jae Yeon Choi a b c , Yun-Sang Lee a , Dong Soo Lee a c , June-Key Chung a b c , …
Nanoparticles modified by encapsulation of ligands with a long alkyl chain to affect multispecific and multimodal imaging
The attachment of specific ligands to the surfaces of nanoparticles is important for medical
and biologic imaging. However, covalent modification of nanoparticles has inherent problems …
and biologic imaging. However, covalent modification of nanoparticles has inherent problems …
Simultaneous multiparametric PET/MRI with silicon photomultiplier PET and ultra-high-field MRI for small-animal imaging
Visualization of biologic processes at molecular and cellular levels has revolutionized the
understanding and treatment of human diseases. However, no single biomedical imaging …
understanding and treatment of human diseases. However, no single biomedical imaging …
Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevican
…, Y Ghotmi, JM Wolfe, S Dubey, BY Yang… - Advanced …, 2021 - Wiley Online Library
Glioblastoma (GBM) is the most common and deadliest form of brain tumor and remains
amongst the most difficult cancers to treat. Brevican (Bcan), a central nervous system (CNS)‐…
amongst the most difficult cancers to treat. Brevican (Bcan), a central nervous system (CNS)‐…
Synthesis of novel 68Ga-labeled amino acid derivatives for positron emission tomography of cancer cells
OBJECTIVES: We developed amino acid derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic
acid (DO2A) and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid (DO3A) that …
acid (DO2A) and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid (DO3A) that …
Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography
INTRODUCTION: Although many sentinel lymph node (SLN) imaging agents labeled with
99m Tc have been developed, no positron-emitting agent has been specifically designed for …
99m Tc have been developed, no positron-emitting agent has been specifically designed for …
Syntheses of 2-Nitroimidazole Derivatives Conjugated with 1,4,7-Triazacyclononane-N,N′-Diacetic Acid Labeled with F-18 Using an Aluminum Complex Method …
Hypoxia imaging is important for diagnosis of ischemic diseases, and thus various 18 F-labeled
radiopharmaceuticals have been developed. However, 18 F-labeling requires multistep …
radiopharmaceuticals have been developed. However, 18 F-labeling requires multistep …
[HTML][HTML] A Gas Phase Route to [18F]fluoroform with Limited Molar Activity Dilution
Positron emission tomography (PET) is an important imaging modality for biomedical research
and drug development. PET requires biochemically selective radiotracers to realize full …
and drug development. PET requires biochemically selective radiotracers to realize full …